DRW Holdings »

Fate Therapeutics shares owned by DRW Holdings

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by DRW Holdings from 13F filings

Historical chart of DRW Holdings investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by DRW Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by DRW Holdings

Quarter filed Position value Share count Share price at filing
2024-06-30 $71k 22k 3.28

More positions owned by DRW Holdings

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Spdr Gold Tr Gold Shs Call Option (GLD)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Grayscale Ethereum Com Unt (ETHE)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Oracle Corporation Call Option (ORCL)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Ishares Tr Msci India Etf (INDA)
Facebook Inc cl a Call Option (META)
Alphabet Inc Class A cs Call Option (GOOGL)
Marvell Technology Put Option (MRVL)
Pdd Holdings Sponsored Ads Call Option (PDD)

View all positions for DRW Holdings

Top funds holding Fate Therapeutics

Redmile Group
Vanguard Group
BlackRock
BlackRock
Deep Track Capital
State Street Corporation
Boxer Capital
Bellevue Group
Citadel Advisors
Deerfield Management Company
Johnson & Johnson
D. E. Shaw & Co
Morgan Stanley
Woodline Partners
Baker Bros. Advisors

View all funds holding Fate Therapeutics